Found 60 matching trials
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults PHASE1 To assess the safety and immune response to two experimental vaccines when ...
Show More Learn More & Join Trial
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers PHASE1 To evaluate the safety and immunogenicity of high-titered ALVAC-HIV MN120TM...
Show More Learn More & Join Trial
Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine PHASE1 The purpose of this study is to evaluate the safety and immune response to ...
Show More Location
Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS
Learn More & Join Trial
A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines PHASE1 The purpose of this study is to see if it is safe and effective to give AID...
Show More Location
Dr Frank Judson / Director of Public Health Dept
Learn More & Join Trial
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection PHASE1 The purpose of this study is to see whether an HIV vaccine, ALVAC vCP205, i...
Show More Location
Walter Reed Army Institute of Research
Learn More & Join Trial
Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults PHASE1 This study will evaluate the safety and immune response to five different c...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults PHASE1 This study will evaluate the safety, tolerability, and immune response to d...
Show More Learn More & Join Trial
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers PHASE1 To evaluate the safety and immunogenicity of ALVAC-HIV MN120TMG (vCP205) in...
Show More Learn More & Join Trial
Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial N/A This protocol will study the clinical course of HIV-infection among volunte...
Show More Location
Chon Buri Regional Hospital
Learn More & Join Trial
A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP PHASE2 This international, multi-centre, double-blind vaccine study is a three-arm...
Show More Location
MRC/UVRI and LSHTM Uganda Research Unit
Learn More & Join Trial